Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
BSE CodeCompanyDatePurpose
526622 MFL India 19-Feb-18 Quarterly Results
531882 Kwality 19-Feb-18 Conversion of Convertible Warrants & Compulsorily Convertible Debentures to equity shares of the Company. Postal Ballot
531910 Toheal Pharmach. 19-Feb-18 Accept resignation of Mr. Ketan Hamirani from the Directorship of the company. Any other business with the permission of the Chair. Notice is hereby given that the meeting of the Board of Directors of the Company will be held on the 19th February, 2018 at 12:30 p.m.at the Registered office of the Company situated at Office No. 812, Anand Mangal-3, Opp Core House, Nr. Hirabag, Nr. Rajnagar Club, Ambavadi, Ahmedabad - 380015 to transact the following business: 1. To accept resignation of Mr. Ketan Hamirani from the Directorship of the company. 2. Any other business with the permission of the Chair. (As Per BSE Announcement Dated on 12.02.2018)
532389 Valecha Eng. 19-Feb-18 Board Meeting on Wednesday, 14Th February, 2018 to consider Unaudited Financial Results of the Company for the 3rd Quarter and 9 Months ended 31.12.2017 Quarterly Results (Revised) (As per BSE Announcement dated on 15/02/2018)
532904 Supreme Infra. 19-Feb-18 Quarterly Results
534064 Alliance Integ. 19-Feb-18 Quarterly Results Dear Sir, Pursuant to the Regulation 29, read with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, the 12th day of February, 2018 to, inter alia, consider, approve and take on record the Unaudited Financial Results for the quarter and nine months ended December 31, 2017. It is also informed that in terms of prohibition of Insider Trading Regulations, 2015, issued by Securities Exchange Board of India (SEBI) and Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for the Directors, designated employees and connected persons covered under the code, from February 05, 2018 to February 14, 2018 (both days inclusive). Please take the above on record and inform the members accordingly. Quarterly Results (Revised) (As per BSE Bulletin dated on 12/02/2018) Dear Sir, With reference to the earlier announcement dated 05th February, 2018, pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, this is to inform that, due to unavoidable circumstances, the Meeting of Board of Directors is postponed and scheduled to be held on Monday, the 19th February, 2018, inter alia, consider, approve and take on record the Unaudited Financial Results for the quarter and nine months ended December 31, 2017. Further, in pursuance of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed for Key Managerial Personnel (KMP), Directors and other designated employees of the Company until the beginning of 48th hour after the public announcement of the Un-audited Financial Results are made. Please take the above on record and inform the members accordingly. (As Per BSE Announcement Dated on 12.02.2018)
540025 Advance. Enzyme. 19-Feb-18 Meeting of Board of Directors of Company is scheduled to be held on Monday, February 19, 2018, at registered office of Company, inter alia, to consider and approve additional investment by way of subscription and/or acquisition of Shares of the Company's subsidiary, Advanced Enzymes (Malaysia) Sdn. Bhd.
540267 Flora Corp. 19-Feb-18 Appointment of Mr. Vishwak Ananta as Company Secretary & Compliance officer of the Company.
590075 Lambodhara Text. 19-Feb-18 Preferential Issue of shares
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)